Semaan Sahar, Makkar Jasnit, Lewis Sara, Chatterji Manjil, Kim Edward, Taouli Bachir
1 Department of Radiology, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY 10029.
2 Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
AJR Am J Roentgenol. 2017 Nov;209(5):W263-W276. doi: 10.2214/AJR.17.17993.
The purpose of this study is to discuss the imaging modalities and response criteria used for assessing hepatocellular carcinoma (HCC) response to Y radioembolization, as well as the imaging appearances of treated tumors.
An understanding of the appearance of HCC after Y radioembolization is crucial for accurate evaluation of treatment response. Residual tumor necrosis and enhancement are essential for assessing response. Multiparametric MRI, including DWI and perfusion imaging, plays an emerging role in response assessment and outcome prediction.
本研究的目的是探讨用于评估肝细胞癌（HCC）对钇90放射性栓塞治疗反应的成像方式和反应标准，以及治疗后肿瘤的影像学表现。
了解钇90放射性栓塞治疗后HCC的表现对于准确评估治疗反应至关重要。残余肿瘤坏死和强化对于评估反应至关重要。包括弥散加权成像（DWI）和灌注成像在内的多参数磁共振成像（MRI）在反应评估和预后预测中发挥着越来越重要的作用。
